Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p. <scp> A53T <i>SNCA</i> </scp> Mutation: Data from the Parkinson's Progression Markers Initiative Study
A53T-PD patients have high NfL levels, which could potentially be used as an outcome in clinical trials with disease-modifying agents. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Authors
- Nikolaos Papagiannakis (ORCID: https://orcid.org/0000-0002-8401-8472)
- Christos Koros
- Athina-Maria Simitsi
- Leonidas Stefanis
- and The Parkinson's Progression Markers Initiative
Institutions
- National and Kapodistrian University of Athens (GR)
- Eginition Hospital (GR)
Publication Details
- Journal
- Movement Disorders
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1002/mds.70236
- Primary Topic
- Parkinson's Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00